Skip to main content
editorial
. 2019 Jan 1;5(1):10–22. doi: 10.1016/S2055-6640(20)30273-9

Table 5.

Total HIV-1 DNA analysis

50 mg ABX464 150 mg ABX464 Placebo Difference in proportion*
(95% CI)
Fisher's exact test
P value
All evaluable participants at day 28 n=2 n=14 n=4
Responder 2 (100.0%) 6 (42.9%) 0
Non-responder 0 8 (57.1%) 4 (100.0%)
42.9% (-10.6–67.4) 0.2451

n: number of participants; CI: confidence interval.

*Difference in proportion is calculated for ABX464 150 mg versus placebo